信号传导子及转录激活子-6、前列腺特异抗原在前列腺癌中的表达及意义

中国临床药理学与治疗学 ›› 2009, Vol. 14 ›› Issue (9): 1018-1022.

信号传导子及转录激活子-6、前列腺特异抗原在前列腺癌中的表达及意义

陈荣生¹, 罗冬娇², 陈立¹, 童夏生³, 陈豪⁴, 王恩智⁵

¹台州市中西医结合医院附属浙江中医药大学第一临床医学泌尿外科, 温岭317523, 浙江;
²杭州师范大学钱江学院医学系, 杭州310012, 浙江;
³浙江台州市中西医结合医院附属浙江中医药大学第一临床医学儿科,⁴病理科,⁵检验科, 温岭317523, 浙江

收稿日期:2009-06-18 修回日期:2009-08-09 发布日期:2020-11-03
通讯作者: 童夏生, 男, 硕士, 副主任医师, 研究方向:呼吸内科。E-mail: xshtzg@163.com
作者简介:陈荣生, 男, 大学本科, 副主任医师, 研究方向:泌尿外科。

Expression and significance of signal transducer and activator of transcription 6 and prostate-specific antigen proteins in prostatic carcinoma

CHEN Rong-sheng¹, LUO Dong-jiao², CHEN Li¹, TONG Xia-sheng³, CHEN Hao⁴, WANG Enzhi⁵

¹Department of Urinary Surgery, Taizhou Integrated Western and Traditional Chinese Medicine Hospital, Affiliated to the First Clinical Medicine of Zhejiang Chinese Medical University, Wenling 317523, Zhejiang, China;
²Department of Medical Science, Qianjiang College, Hangzhou Normal University, Hangzhou 310012, Zhejiang, China;
³Department of Pediatrics, ⁴Department of Pathology, ⁵Department of Clinical Laboratory, Taizhou Integrated Western and Traditional Chinese Medicine Hospital, Affiliated to the First Clinical Medicine of Zhejiang Chinese Medical University, Wenling 317523, Zhejiang, China

Received:2009-06-18 Revised:2009-08-09 Published:2020-11-03

摘要/Abstract

摘要： 目的: 观察信号传导子及转录激活子(STAT)-6 和前列腺特异抗原(PSA) 在前列腺癌中的表达, 探讨前列腺癌的发病机制和早期诊断方法。方法: 20 例前列腺癌和36 例良性前列腺增生患者均来自2005 年1 月-2008 年5 月的住院手术者, 免疫组化法测定前列腺组织STAT-6 和PSA 蛋白的表达, 电化学发光法测定血清总PSA(tPSA) 及游离PSA (fPSA), 彩色多普勒超声测量前列腺体积(PV), 计算f/t 比值和前列腺特异抗原密度(PSAD) 。结果: 前列腺癌组前列腺组织的STAT-6 和PSA 蛋白的表达水平(OD 值分别为0.24±0.08 和0.31±0.09) 显著高于良性前列腺增生组(OD 值分别为0.12±0.06 和0.20±0.07)(P <0.01) 。前列腺癌组血清tPSA 及fPSA 的含量和PSAD 值[分别为(43± 26) 、(3.8±2.2) ng/mL 和(0.88±0.66) ng·mL^-1 ·cm^-3] 显著高于良性前列腺增生组[分别为(6±4) 、(1.2±0.8) ng/mL 和0.12±0.09) ng·mL^-1·cm^-3] 。两组之间f/t 比值和PV 值[分别为(0.14±0.10) 、(61±35) cm³ ;(0.31±0.48) 、(47±24) cm³] 比较差异无统计学意义(均P >0.05) 。结论: STAT-6和PSA 可能参与了前列腺癌的形成过程, 血清tPSA、fPSA 、PSAD 可作为前列腺癌(PCa) 筛查良好的指标。

关键词: 前列腺癌, 信号传导子及转录激活子, 前列腺特异抗原, 良性前列腺增生

Abstract: AIM: To observe the expressions of signal transducer and activator of transcription (STAT)- 6 and prostate-specific antigen(PSA) proteins in prostatic carcinoma, and approach the pathogenesis and early diagnosis methods of prostatic carcinoma. METHODS: All patients were operated during January 2005 to May 2008 including 20 cases of prostatic carcinoma and 36 cases of benign prostatic hyperplasia. The expressions of STAT-6 and PSA proteins were detected by immunohistochemical methods in prostate tissue. The concentration of totall PSA(tPSA) and free PSA(fPSA) in serum were detected by electrochemiluminescence. The prostate volume was measured by color doppler ultrasound. The ratio of f/ t value and prostate specific antigen density (PSAD) were calculated. RESULTS: The expressions of STAT-6 and PSA protein were significantly higher in prostatic carcinoma group (Optical Density: 0.24±0.08 and 0.31±0.09, respectively) than those in benign prostatic hyperplasia group(Optical Density: 0.12±0.06 and 0.20±0.07, respectively) (all P <0.01). The concentrations of tPSA and fPSA in serum and PSAD were significantly higher in prostatic carcinoma group [(43±26) ng/mL, (3.8± 2.2) ng/mL and (0.88±0.66) ng·mL^-1·cm^-3, respectively] than those in benign prostatic hyperplasia group[(6±4) ng/mL, (1.2±0.8) ng/mL and (0.12±0.09) ng·mL^-1 ·cm^-3, respectively] (all P <0.01). There were no statistically differences in the f/t value and prostate volume between prostatic carcinoma group[(0.14±0.10), (61±35) cm³, respectively] and benign prostatic hyperplasia group(0.31± 0.48, 47±24 cm³, respectively) (all P >0.05). CONCLUSION: STAT-6 and PSA may participate in the development of prostatic carcinoma. The concentrations of tPSA and fPSA in serum and PSAD can be applied as effective screening targets for prostatic carcinoma diagnosis.

Key words: prostatic carcinoma, signal transducer and activator of transcription, prostate specific antigen, benign prostatic hyperplasia

中图分类号:

R965.2

陈荣生, 罗冬娇, 陈立, 童夏生, 陈豪, 王恩智. 信号传导子及转录激活子-6、前列腺特异抗原在前列腺癌中的表达及意义[J]. 中国临床药理学与治疗学, 2009, 14(9): 1018-1022.

CHEN Rong-sheng, LUO Dong-jiao, CHEN Li, TONG Xia-sheng, CHEN Hao, WANG Enzhi. Expression and significance of signal transducer and activator of transcription 6 and prostate-specific antigen proteins in prostatic carcinoma[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(9): 1018-1022.

参考文献

[1] Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2008[J]. CA Cancer J Clin, 2008, 58(2): 71-96.
[2] 叶洁梅, 周洁, 冷静.瘦素与前列腺癌[J]. 基础医学与临床, 2008, 28(7): 778-780.
[3] 周华斐, 王昕昕, 童夏生, 等.哮喘大鼠中性粒细胞基质金属蛋白酶-9 和血清基质金属蛋白酶抑制剂-1 的表达及地塞米松对其的影响[J]. 中国临床药理学与治疗学, 2008, 13(8): 870-873.
[4] 盛青. STAT6 与支气管哮喘[J]. 国外医学呼吸系统分册, 2004, 24(1): 12-14.
[5] 赵维明, 修有成, 徐勇.阳离子聚酰胺型树技术聚合物介导STAT3- shRNA 对前列腺癌生长的抑制作用[J]. 中华肿瘤杂志, 2007, 29(8): 575-579.
[6] 高丽芳, 徐德启, 李峰, 等.RNAi 沉默STAT3 基因对人前列腺癌及PC3 细胞裸鼠移植瘤生长的抑制作用[J]. 中华泌尿外科杂志, 2007, 28(4): 277-279.
[7] Bruns HA, Kaplan MH. The role of constitutively active Stat6 in leukemia and lymphoma[J]. Crit Rev Oncol Hematol, 2006, 57(3): 245-253.
[8] 陈晓红, 钟南山, 张卫东, 等.布地奈德对哮喘小鼠气道重塑及JAK1 STAT6 表达的影响[J]. 中华医学杂志, 2007, 87(23): 1627-1632.
[9] Zhang MS, Zhou YF, Zhang WJ, et al. Apoptosis induced by short hairpin RNA-mediated STAT6 gene silencing in human colon cancer cells[J]. Chin Med J, 2006, 119(10): 801-808.
[10] 李品东, 袁琴, 杨贤子, 等.结直肠癌细胞IL-4/Stat6信号传导活性与调节基因差异性表达相关性研究[J]. 中华肿瘤防治杂志, 2007, 14(24): 1841-1845.
[11] Das S, Roth CP, Wasson LM, et al. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer[J]. Prostate, 2007, 67(14): 1550-1564.
[12] 秦永斌, 冯琼, 龚志强, 等.P504S 、p63 、CK34 βEl2、PSA 在前列腺癌中的表达及其临床意义[J]. 中国中西医结合外科杂志, 2008, l4(4): 430-432.
[13] Batabyal SK, Majhi R, Basu PS. Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer[J]. Neoplasma, 2009, 56(1): 68-71.
[14] 林涛, 王友宝, 陈长宣, 等.PSA 及其F/T 值与PSAD对前列腺癌和增生鉴别价值[J]. 齐鲁医学杂志, 2008, 23(3): 233-235.
[15] 赵耀瑞, 徐勇, 张殿举, 等.血清PSA、PSAD 和PSAT 在前列腺穿刺活检中的意义[J]. 中华泌尿外科杂志, 2005, 26(9): 622-625.